Sun Pharma Advanced Research Company Ltd

NSE: SPARC · BSE: 532872 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹197.00
Market cap: ₹6,393 Cr
Revenue (annual): ₹1,879 Cr
Net profit (annual): ₹1,553 Cr
P/E (TTM): 4.0×Sector 47.4×
Promoter holding: 65.67%+0.00% QoQ
FII holding: 3.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Annual General Meeting 3 Promoter Reclassification 2 Management Change 2 Fund Raise 2 Business Update 2 Board Meeting Date 2 Merger & Restructuring 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 09:06 IST BSE

Merger & Restructuring

Sun Pharma Advanced Research Company Merger & Restructuring Worth ₹1,833 Cr

Sun Pharma Advanced Research Company Ltd (SPARC) has agreed to sell its FDA-granted Priority Review Voucher for US $195 million (₹1833.00 Crore). The transaction, subject to customary closing conditions and HSR antitrust clearance, will provide significant capital to accelerate SPARC's internal pipeline development and strengthen its innovation strategy.

Value: ₹1,833 Cr

Read the filing ↗